Skip to content

Clinical trials

Mastocytosis, Systemic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20152
20183
20191
20202
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status3
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation4
University Hospital, Toulouse3
AB Science2
Cogent Biosciences, Inc.2
Novartis Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire, Amiens1
Patara Pharma1
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic17
Mastocytosis6
Leukemia, Mast-Cell4
Hematologic Diseases2
Hypersensitivity2
Immune Complex Diseases2
Immune System Diseases2
Leukemia2
Mastocytosis, Cutaneous2
Piebaldism2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.